Christine Granfield
About Christine Granfield
Christine Granfield is the Vice President of Regulatory Affairs and Quality at Leap Therapeutics, where she has worked since 2020. She has extensive experience in regulatory affairs, having held senior positions at Novartis Oncology and Genzyme, among others.
Current Role at Leap Therapeutics
Christine Granfield serves as the Vice President of Regulatory Affairs & Quality at Leap Therapeutics. She joined the company in August 2020 and has since been responsible for overseeing regulatory compliance and quality assurance processes. Her role involves developing and implementing regulatory strategies to support the company's initiatives in the biotechnology sector.
Previous Experience at Novartis Oncology
Prior to her current position, Christine Granfield worked at Novartis Oncology as the Senior Director of Regulatory Affairs for Companion Diagnostics from 2011 to 2016. During her five years at Novartis, she led the development of regulatory strategies and submissions for companion diagnostics, which are essential for oncology personalized medicine programs.
Professional Background in Regulatory Affairs
Christine Granfield has extensive experience in regulatory affairs, having held various positions throughout her career. She worked at Genzyme Corporation as Senior Director of Regulatory Affairs from 1998 to 2011. Additionally, she served as a Regulatory Engineer at B. Braun Medical from 1992 to 1994 and as a Biomedical Engineer at the FDA's Office of Device Evaluation from 1990 to 1992.
Educational Qualifications
Christine Granfield earned a Bachelor of Science in Engineering (B.S.E.) in Biomedical Engineering from The Catholic University of America, where she studied from 1986 to 1990. This educational background laid the foundation for her career in regulatory affairs and biomedical engineering.
Membership and Consulting Experience
Christine Granfield is a member of the Regulatory Affairs Professional Society, which reflects her commitment to staying informed about industry standards and practices. She also previously served as an independent regulatory consultant with Granfield Associates LLC, providing expertise in regulatory strategy and compliance.